Halofantrine
- Level
- Commodity
- Parent
- 51101900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101911This classification denotes an antimalarial agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q2OS4303HZ. European Medicines Agency schedules Halofantrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07998MIG. Halofantrine generally arises in the molecular formula C26H30CL2F3NO. The term HALOFANTRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, no. 10 1980, list 20.) HALOFANTRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule halofantrine under HS 29221980 and SITC 51461. As of Q4 2014, HALOFANTRINE remains the US FDA Preferred Term for this commodity. Halofantrine bears US NLM identifiers UMLS ID C0120726 and NCI Concept Code C65838. SMILES: CLC1C2CC(C(O)CCN(CCCC)CCCC)C3C(C2CC(CL)C1)CC(CC3)C(F)(F)F.
Same parent
Under 51101900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.